Cancer
Li-Fraumeni syndrome, a hereditary cancer syndrome associated with TP53 gene mutations, poses a challenge in classification due to disease-causing variants with lower than average penetrance. Research conducted to identify TP53 variants flagged as having reduced penetrance by genetic testing laboratories and analyzed their functional, bioinformatic, frequency, and clinical features. The
Cancer
An Australian cancer patient has traveled 10,000 miles to meet his UK stem cell donor, an extraordinary act of kindness that has saved his life. Luke Melling, 31, flew from Melbourne to Grantham in Lincolnshire to meet Alastair Hawken, the 51-year-old who donated his stem cells to help Melling
Cancer
Researchers from Ural State Medical University have made a significant breakthrough in cancer immunotherapy using magnetic nanoparticles. According to their study, the use of monocyte-derived dendritic cells (moDCs) sensitized by cancer-associated antigens and loaded with magnetic nanoparticles (MNPs) enhances the T-cell mediated anti-tumor immune response. This innovative approach has the
Cancer
Researchers at the Chinese Academy of Medical Sciences have made a significant breakthrough in cancer treatment by developing a novel formulation of paclitaxel that exhibits strong anti-tumor effects and safety in combination with immunotherapy. The study, published in Materials Today Bio, demonstrates the potential of self-assembled nanoparticles to enhance cancer
Cancer
Researchers at Air Force Medical University have made significant progress in the development of cancer nanovaccines, leveraging nanovehicles to enhance immune responses and create personalized vaccines. According to the study, cancer vaccines can stimulate the immune system to target and destroy cancer cells by recognizing antigens and adjuvants. The research
Cancer
Researchers from the Institute of Nano Science and Technology have made a significant breakthrough in cancer gene therapy by developing a novel nanomaterial that can target and treat glioma, a type of brain cancer, with unprecedented efficiency. The innovative approach involves the use of exfoliated 2D transition-metal dichalcogenide (TMDCs)-based
Cancer
Pharmac, New Zealand's public healthcare provider, has announced the funding of new cancer treatments and the expansion of existing ones, promising improved access for thousands of patients. The move includes funding for immune checkpoint inhibitors, targeted cancer medicines, and antibiotics to combat antibiotic-resistant infections. Pharmac's decision
Cancer
Researchers from Tianjin University have made a significant breakthrough in cancer therapy by developing a nanomedicine that can amplify oxidative stress, leading to potent anticancer activity. The new approach combines chemotherapy and photodynamic therapy to address the limitations of single modal therapies and improve therapeutic outcomes. The nanomedicine, which is
Cancer
A groundbreaking study from University College Dublin has unveiled the enormous potential of Artificial Intelligence (AI) in transforming medical imaging for patients with cancer. According to the research, AI can significantly enhance the accuracy and efficiency of cardiotoxicity assessments in patients undergoing cancer therapy. The systematic review, which analyzed seven
Cancer
Researchers at the Aoyang Institute of Cancer have developed a new approach to treating gastric cancer using modified vesicles derived from human umbilical cord mesenchymal stem cells. The study, published in the Journal of Controlled Release, found that these modified vesicles, known as Neu/MSC-sEVs, were able to effectively inhibit
Cancer
Research conducted at Peking University Cancer Hospital and Institute has yielded promising results in the treatment of gastric cancer. The study, which has been peer-reviewed and published in JAMA Oncology, investigated the efficacy and safety of adding atezolizumab to trastuzumab plus chemotherapy in patients with locally advanced, HER2-positive gastric or
Cancer
The UAE Ministry of Tolerance and Coexistence, under the leadership of Sheikh Nahyan bin Mubarak Al Nahyan, has reaffirmed its commitment to advancing public health and developing world-class healthcare services. Recently, the Minister officially inaugurated the Mediclinic Hospitals Cancer Centres Annual Congress in Abu Dhabi, which brought together a diverse
